Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAOR.L Regulatory News (AOR)

  • There is currently no data for AOR

AGM Update

17 Nov 2005 07:01

Aortech International PLC17 November 2005 For immediate release 17 November 2005 AorTech International plc AGM Update and Notice of Poll Meeting AorTech International plc (AIM:AOR) today updates shareholders following itsAnnual General Meeting on 26 October 2005. At the AGM, all Resolutions were passed by a show of hands. However, in thecases of resolution number 5 concerning the proposed election of Jon PeterPither as a Director and resolution number 7 concerning the proposed change ofname of the Company to AorTech Biomaterials plc, a poll was validly requested bya person in attendance at the meeting. It has been determined that the pollwill be taken at 12 noon on Tuesday, 6 December 2005, at BuchananCommunications, 107 Cheapside, London, EC2V 6DN. All shareholders entitled toattend the Annual General Meeting will be entitled to attend the taking of thepoll. Jon Pither was appointed as a Non-Executive Director on 1 March 2004 and tookover as Chairman on 13 May 2005. Jon has Board and City institutionalexperience and also knowledge and experience of the challenges facing quotedsmall cap companies with emerging technologies. The Board unanimously supportthe election of Jon Pither to allow him to continue as Chairman. The objective in proposing the change of the name from AorTech International plcto AorTech Biomaterials plc is to reflect more accurately the future of theCompany's focus on the development and commercial applications of itsbiomaterial products. The Company's subsidiary in Australia, where the researchand operational activity is now centred, is named AorTech Biomaterials Pty Ltd.Given that the UK operation is administrative rather than marketing related, thecosts of such a change would be relatively minimal in terms of reprinting ofstationery and other related items. Shareholders are being sent an explanatory letter early next week, together witha proxy card, and are required to lodge the card in the Registrars' offices nolater than noon on Monday, 5 December 2005 in order for it to be valid. Proxiesthat were lodged prior to the Annual General Meeting will remain valid unlessrevoked by submitting the new proxy card. Copies of the letter to theshareholders and the poll card will be made available to the public from thedate of the announcement for a period of one month, free of charge, and can beobtained from the Company's office whose address is given below. The poll will be taken at 12 noon on Tuesday, 6 December, 2005 at BuchananCommunications and the results announced to the Stock Exchange as soon aspossible thereafter. Shareholders are entitled to attend. Return of the proxyform does not prevent a member from attending the poll and voting in person. For further information please contact: AorTech International plc 0870 850 8286David Parsons, Company Secretary Buchanan Communications 020 7466 5000Ben Willey, Lisa Baderoon, Rebecca Skye Dietrich AorTech International plcPrestige Travel SuiteBarclays Bank House81-83 Victoria RoadSurbitonSurreyKT6 4NS This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Jun 20207:00 amRNSChange of Name and Rebranding
8th Jun 20207:00 amRNSUpdate on Elective Surgery and Customer Orders
27th May 20207:00 amRNSNew Patent
20th May 20207:00 amRNSGrant Funding for Subsidiary
13th May 20207:00 amRNSTrading Update
14th Apr 202010:27 amRNSFurther Update re COVID-19
2nd Apr 20202:13 pmRNSHolding(s) in Company
1st Apr 20201:36 pmRNSDirector/PDMR Shareholding
31st Mar 202010:28 amRNSResult of General Meeting and Total Voting Rights
30th Mar 20203:37 pmRNSUpdate re Acquisition of RUA and COVID-19
25th Mar 20207:00 amRNSUpdate re Acquisition and General Meeting
11th Mar 20207:00 amRNSProposed Acquisition of RUA Medical & Name Change
21st Jan 20207:00 amRNSExtension to Agreement with RUA Medical
6th Jan 20207:00 amRNSHeart Valve Development Update
2nd Dec 20197:00 amRNSNew Share Option Scheme and Grant of Share Options
29th Nov 20197:00 amRNSHalf-year Report
27th Nov 20191:09 pmRNSNew Licence Agreement
11th Oct 20197:00 amRNSTrading Update
3rd Sep 20191:14 pmRNSHolding(s) in Company
19th Aug 20192:53 pmRNSResult of AGM
5th Aug 20191:36 pmRNSPosting of Report & Accounts and Notice of Meeting
29th Jul 201912:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSFinal Results
8th Jul 201911:05 amRNSSecond Price Monitoring Extn
8th Jul 201911:00 amRNSPrice Monitoring Extension
19th Jun 20197:01 amRNSChange of Adviser
19th Jun 20197:00 amRNSDirectors' Disclosures
17th Jun 201910:47 amRNSDirectors' Disclosures
14th May 20197:00 amRNSTrading Update
24th Jan 201912:36 pmRNSCompany Update
22nd Nov 20187:00 amRNSInterim Results
15th Oct 20185:34 pmRNSHolding(s) in Company
5th Sep 20187:00 amRNSHolding(s) in Company
30th Aug 201811:18 amRNSHolding(s) in Company
23rd Aug 20182:03 pmRNSResult of AGM
23rd Aug 20187:00 amRNSAGM Statement
26th Jul 20183:33 pmRNSHolding(s) in Company
25th Jul 20184:40 pmRNSSecond Price Monitoring Extn
25th Jul 20184:35 pmRNSPrice Monitoring Extension
20th Jul 20187:00 amRNSFinal Results
4th Jul 20187:00 amRNSNew Patent Issued
28th Jun 20187:00 amRNSDevelopment and Supply Agreement with RUA Medical
26th Jun 201812:49 pmRNSNew Patent Issued
19th Jun 20189:30 amRNSDevelopment Agreement Signed
15th Jun 20183:54 pmRNSHolding(s) in Company
13th Jun 201811:47 amRNSHolding(s) in Company
8th Jun 201812:02 pmRNSResult of GM and TVR
8th Jun 20187:00 amRNSResult of Open Offer
22nd May 201812:00 pmRNSPosting of Circular
21st May 20187:00 amRNSConditional Placing and Proposed Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.